ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 444,04
0,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. BiOasis Technologies Inc (BTI)

  7. BiOasis Technologies Inc (BTI) Actualités

BTI

BiOasis Technologies (BTI)

BiOasis Technologies Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:BTI
DateHeureSourceTitreSymboleSociété
21/03/202412h50PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BTITSXV:BTIBiOasis Technologies Inc
21/03/202412h47PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - BTITSXV:BTIBiOasis Technologies Inc
23/01/202315h51PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BTITSXV:BTIBiOasis Technologies Inc
23/01/202315h48PR Newswire (Canada)IIROC Trading Resumption - BTITSXV:BTIBiOasis Technologies Inc
23/01/202314h53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BTITSXV:BTIBiOasis Technologies Inc
23/01/202314h50PR Newswire (Canada)IIROC Trading Halt - BTITSXV:BTIBiOasis Technologies Inc
24/02/202014h35PR Newswire (Canada)Growth Company Investor Presentations Now Available for On-Demand ViewingTSXV:BTIBiOasis Technologies Inc
14/02/202014h35PR Newswire (Canada)Live Investor Conference & Webinar: Growth Company CEOs Present February 20thTSXV:BTIBiOasis Technologies Inc
25/07/201415h30Marketwired CanadabiOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the BrainTSXV:BTIBiOasis Technologies Inc
21/06/201401h30MarketwiredbiOasis Appoints New Chief Financial Officer and Corporate SecretaryTSXV:BTIBiOasis Technologies Inc
16/06/201415h00MarketwiredbiOasis Enters Investor Relations Agreement with Gale Capital CorporationTSXV:BTIBiOasis Technologies Inc
08/05/201415h00MarketwiredbiOasis Secures DTC EligibilityTSXV:BTIBiOasis Technologies Inc
06/05/201415h00Marketwired CanadabiOasis Delivers siRNA to the Brain Using its Transcend Peptide VectorTSXV:BTIBiOasis Technologies Inc
24/04/201415h00MarketwiredbiOasis Discovers the Keys to Transcend to Advance Its Program for the Delivery of Therapeutics Across the Blood-Brain BarrierTSXV:BTIBiOasis Technologies Inc
03/04/201415h00MarketwiredbiOasis Presents Results From It's BT2111 Program at International Cancer Research ConferenceTSXV:BTIBiOasis Technologies Inc
27/03/201414h00MarketwiredbiOasis Receives Patent Allowances for Lysosomal Storage Disease Therapeutic in Europe and CanadaTSXV:BTIBiOasis Technologies Inc
17/03/201414h00MarketwiredbiOasis Enters Into a License Agreement With Medimmune for Second Generation Versions of biOasis's TranscendTSXV:BTIBiOasis Technologies Inc
24/02/201415h00MarketwiredbiOasis to Begin Trading on OTCQX® Marketplace in the U.S.TSXV:BTIBiOasis Technologies Inc
04/12/201323h45MarketwiredOption Grant-biOasis Technologies Inc.TSXV:BTIBiOasis Technologies Inc
12/11/201314h00Marketwired CanadaStudy Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Ti...TSXV:BTIBiOasis Technologies Inc
17/10/201315h00Marketwired CanadabiOasis Presents Research Results on BT2111 (Transcend-Trastuzumab) at the AACR-NCI-EORTC International Conference on Molecul...TSXV:BTIBiOasis Technologies Inc
01/10/201315h00Marketwired CanadabiOasis Engages Liolios Group to Lead New Investor Relations ProgramTSXV:BTIBiOasis Technologies Inc
04/09/201320h04Marketwired CanadabiOasis to Present at the 2013 Gateway Conference on September 10TSXV:BTIBiOasis Technologies Inc
07/08/201315h00Marketwired CanadabiOasis Technologies Inc. Announces Notice of Allowance for Key Lysosomal Storage Disease Patent From the US Patent and Trade...TSXV:BTIBiOasis Technologies Inc
18/06/201315h00Marketwired CanadaCEO Letter to ShareholdersTSXV:BTIBiOasis Technologies Inc
09/04/201315h00Marketwired CanadabiOasis's Update on the BT2111-Herceptin(R) ProgramTSXV:BTIBiOasis Technologies Inc
13/02/201319h00Marketwired CanadabiOasis Named to 2013 TSX Venture 50(R)TSXV:BTIBiOasis Technologies Inc
14/12/201214h00Marketwired CanadabiOasis Technologies Year in Review 2012TSXV:BTIBiOasis Technologies Inc
03/12/201214h00Marketwired CanadabiOasis Enters Into a Research Collaboration Agreement with UCBTSXV:BTIBiOasis Technologies Inc
24/09/201215h00Marketwired CanadabiOasis Receives Preliminary Histopathology (Tissue Toxicity) Results on Its Herceptin(R) BT2111 ProgramTSXV:BTIBiOasis Technologies Inc
 Showing the most relevant articles for your search:TSXV:BTI

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
USI
USTECH100
US Tech 100
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
NYSE
NKE
Nike
EU
DG
Vinci
NASDAQ
MSFT
Microsoft
EU
PX1
CAC 40
EU
VIV
Vivendi
NYSE
JPM
JP Morgan Chase
EU
VK
Vallourec
EU
GLE
Societe Generale
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés